retatrutide vs tirzepatide efficacy safety vs. Tirzepatide: The Next-Gen GLP-1 Showdown Efficacy and Safety of GLP‐1
Description
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Neither tested dose reduction protocols
Cell Mol Neurobiol 36:203217 Min T, Bain SC (2021) The role of tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes: the SURPASS clinical trials
If necessary, we may recommend lab tests to ensure the medication is a safe option for you
In clinical trials, more than 9 out of 10 people didnt report significant tiredness
Why Choose Klinic in Colorado
